Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Mallinckrodt
Medtronic
Boehringer Ingelheim
AstraZeneca

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Eleclazine

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Eleclazine: Patents, clinical trial progress, indications

Eleclazine is an investigational drug.

There have been 6 clinical trials for Eleclazine. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2014.

The most common disease conditions in clinical trials are Long QT Syndrome, Syndrome, and Cardiomyopathy, Hypertrophic. The leading clinical trial sponsors are Gilead Sciences and [disabled in preview].

There are eight US patents protecting this investigational drug and one hundred and thirty-one international patents.

Recent Clinical Trials for Eleclazine
TitleSponsorPhase
Effect of Eleclazine on QT, Safety, and Tolerability in Adults With Long QT2 SyndromeGilead SciencesPhase 1
Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal FunctionGilead SciencesPhase 1
Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic FunctionGilead SciencesPhase 1

See all Eleclazine clinical trials

Clinical Trial Summary for Eleclazine

Top disease conditions for Eleclazine
Top clinical trial sponsors for Eleclazine

See all Eleclazine clinical trials

US Patents for Eleclazine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Eleclazine   See Pricing Fused heterocyclic compounds as ion channel modulators Gilead Sciences, Inc. (Foster City, CA)   See Pricing
Eleclazine   See Pricing Fused heterocyclic compounds as ion channel modulators Gilead Sciences, Inc. (Foster City, CA)   See Pricing
Eleclazine   See Pricing Methods of treating hypertrophic cardiomyopathy Gilead Sciences, Inc. (Foster City, CA)   See Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Merck
McKinsey
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.